互联网医疗等解决方案
Search documents
创业慧康(300451)10月23日主力资金净买入443.58万元
Sou Hu Cai Jing· 2025-10-24 01:12
Core Viewpoint - The stock of Chuangye Huikang (300451) has shown a recent increase in price and trading activity, with significant net inflows from institutional and retail investors, despite a decline in financial performance year-over-year [1][2][5]. Financial Performance - Chuangye Huikang reported a main revenue of 577 million yuan for 2025, a year-on-year decrease of 20.65% [5] - The net profit attributable to shareholders was -80.55 million yuan, representing a year-on-year decline of 394.25% [5] - The second quarter of 2025 saw a single-quarter main revenue of 286 million yuan, down 18.48% year-on-year [5] - The company has a debt ratio of 20.5% and a gross profit margin of 51.45% [5] Stock Performance and Trading Activity - As of October 23, 2025, the stock closed at 4.72 yuan, up 3.28% with a trading volume of 419,000 hands and a total transaction amount of 194 million yuan [1] - Over the past five days, the stock has experienced fluctuations in net capital inflows, with a net inflow of 443.58 million yuan from main funds on October 23 [2][3] - The financing balance stood at 489 million yuan on October 23, with a net financing purchase of 6.54 million yuan [3] Industry Comparison - Chuangye Huikang's total market value is 7.312 billion yuan, compared to the software development industry average of 13.129 billion yuan [5] - The company has a price-to-earnings ratio of -45.38, while the industry average is 88.08 [5] - The net profit margin for Chuangye Huikang is -12.54%, slightly worse than the industry average of -12.34% [5] Institutional Ratings - In the last 90 days, four institutions have rated the stock as a buy, with an average target price of 6.37 yuan [6]